Applying Dry Powder Coatings - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Applying Dry Powder Coatings
The authors experiment with a resonant acoustic mixer as a method for dry powder coating.


Pharmaceutical Technology
Volume 35, Issue 10, pp. 94-102

Materials and methods

A selection of pharmaceutical powders were chosen as host particles with different particle sizes, particle shapes, and chemistry: ibuprofen (50 grade and 90 grade, BASF), acetaminophen (micronized, Mallinckrodt Baker), proprietary active pharmaceutical ingredients (API "A" and API "B," Pfizer), mannitol (powder grade, SPI Pharma), and lactose monohydrate (310 grade, Foremost Farms). Four guest particles were selected and represented a range of small microsized or nanosized particles commonly used as glidants or lubricants in solid dosage formulations: hydrophobic silicon dioxide (Aerosil R972, Evonik/Degussa), hydrophilic silicon dioxide (Aerosil 200, Evonik/Degussa), titanium dioxide (USP grade, Brenntag Specialties), and magnesium stearate (HyQual, Mallinckrodt Baker).

RAM dry powder coating. A resonant acoustic mixer (LabRAM, 500 g capacity, Resodyn) was used to prepare the coated particles in small batches (~20 g). The host and guest particles were placed into amber glass bottles and mixed for as much as 10 min at a frequency of 60–61 Hz and a mechanical driver magnitude of 75–80 times the acceleration of gravity. The mixing oscillation mixing frequency was optimized by the RAM driver control module to mix the powder at resonance.

Comil dry powder coating. An overdriven comil (model 197, Quadro Engineering) was also used to prepare dry-coated particles. Details of this approach for coating were previously reported (1). This process required the selection of comil operating conditions (i.e., screens, impeller, operating speed, and the powder feeding rate) to maximize dispersion of the guest particles and enable throughput without screen blinding. A round-edged impeller rotating at a tip speed of 2.4 m/s and round hole screens (0.457 to 0.813 mm opening) were selected to maximize residence time and minimize host-particle attrition. The screen opening size was slightly above the maximum particle size of the host particle and the powder was manually charged to the mill at 10–200 g/min.

Powder characterization. Photomicrographs were taken with a scanning electron microscope (FEI Quanta 200, FEI) using a working distance of 10 mm with an accelerating voltage of 5 kV. The particle-size distribution was determined using a laser-diffraction particle-size analyzer (Sympatec HELOS/RODOS, Sympatec) with dry dispersion capability. The bulk density was determined using the USP <616> method. The flow behavior of powders equilibrated at 50% relative humidity was determined using an annular shear cell (Schulze Ring Shear Tester model RST-XS, Wolfenbüttel, Germany) using a preconsolidation stress of 4 kPa. The ratio of the principal consolidation stress to the unconfined yield strength was used to calculate the flow function coefficient (FFC). The FFC was used as an indicator of powder flow performance. Powders with FFC values between 4 and 10 were considered easy flowing, and higher FFC values indicate superior flow behavior (9).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Pharmaceutical Technology,
Click here